Vivus Beefs Up Qsymia Efforts As Eisai Prepares To Launch Belviq
This article was originally published in The Pink Sheet Daily
Executive Summary
The obesity drug market will see substantial commercial investment in the second half of 2013. Vivus is planning its first DTC advertising for Qsymia and continuing its search for a big pharma partner, while Eisai/Arena have been cleared by the Drug Enforcement Agency to launch Belviq.